Results
Piramal Pharma Q2 Revenue Up 28% YoY, Upgrades FY27 Outlook
Piramal Pharma reported 28% YoY revenue growth to ₹2,617 Cr in Q2FY27 and 23% growth to ₹4,887 Cr in H1FY27.
EBITDA surged 72% YoY in both periods with margin expansion of over 350bps, driven by stron
